Mammography Market Size, Share & Trends Report

Mammography Market Size, Share & Trends Analysis Report By Product (Film Screen, Digital), By Technology (Breast Tomosynthesis, Digital), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-353-9
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the mammography market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for mammography market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of mammography market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Mammography Market Categorization:

The mammography market was categorized into four segments, namely product (Film Screen Systems, Digital Systems, Analog Systems, 3D Systems), technology (Breast Tomosynthesis, CAD Mammography, Digital Mammography), end-use (Hospitals, Specialty Clinics, Diagnosis Centers), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The mammography market was segmented into product, technology, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The mammography market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S., Canada, the UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Mammography market companies & financials:

The mammography market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • FUJIFILM HOLDINGS CORPORATION  -  Fujifilm Corporation Group Companies is a wholly owned subsidiary of Fujifilm Holdings Corporation. The company develops, manufactures, and markets products in two key business segments: imaging solutions and healthcare & material solutions. The company has subsidiaries all across the globe, and it is focused on emerging economies, such as Brazil, Russia, India, and China (BRICs) as well as Turkey, the Middle East, & Southeast Asia and is establishing local subsidiaries in these markets. 

  • HOLOGIC INC.  -  Hologic, Inc. is a company that specializes in the development, production, and provision of top-tier diagnostics, medical imaging devices, and surgical products. Their mission is to enhance women’s health and wellness by facilitating the early detection of diseases. The company operates through four main divisions: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics division offers a broad array of diagnostic products primarily used for disease screening and diagnosis. The Breast Health division provides a comprehensive suite of solutions for breast cancer care, including breast imaging and analytics, such as 2D and 3D digital mammography systems, reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy devices, specimen radiology, ultrasound, and connectivity solutions, and breast-conserving surgery products. The GYN Surgical division’s products include the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health division offers products such as the Horizon DXA, a dual-energy x-ray system that measures bone density and performs body composition assessments, and the Fluoroscan Insight FD mini-C-arm. 

  • KONINKLIJKE PHILIPS N.V.  -  Koninklijke Philips N.V. is a multinational corporation specializing in health technology. Its operations are divided into three main sectors: diagnosis & treatment, connected care, and personal health. The diagnosis & treatment division encompasses diagnostic imaging, ultrasound, enterprise diagnostic informatics, and a portfolio of image-guided therapies. The personal health division comprises oral healthcare, mother & child care, personal care, and domestic appliances. The connected care division offers monitoring & analytics, sleep & respiratory care, therapeutic care, connected care informatics, and population health management solutions. The company holds 64,500 patents and operates in North America, Greater China, and other international markets, spanning 100 countries globally. 

  • SIEMENS HEALTHCARE GMBH (SIEMENS HEALTHINEERS)  -  Siemens Healthineers, previously known as Siemens Healthcare, is a division of the Siemens Group. It specializes in the development, production, and marketing of healthcare solutions, including imaging, diagnostics, and advanced therapies and services. These solutions are provided to healthcare providers in over 180 countries. The company operates through three main segments: Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers a range of imaging products, services, and solutions. The Diagnostics segment’s portfolio includes in vitro diagnostic products and services for healthcare providers in laboratory, molecular, and point-of-care diagnostics. The Advanced Therapies segment provides a variety of highly integrated products, solutions, and services across multiple clinical fields. With 170 years of experience in the medical technology field, the company holds 18,000 patents worldwide. Siemens Healthineers has a strong global presence, with operations in more than 70 countries. The company’s primary manufacturing facilities are in the U.S., China, and Germany. 

  • CANON MEDICAL SYSTEMS CORPORATION  -  Canon Medical Systems Corporation is a global provider of a wide array of diagnostic medical imaging solutions. The company is engaged in the development, manufacture, sale, and provision of technical services for medical equipment. This includes diagnostic X-ray systems, medical X-ray CT systems, MRI systems, diagnostic ultrasound systems, radiation therapy systems, diagnostic nuclear medicine systems, medical sample testing equipment, and information systems for medical equipment. Canon Medical Systems has operations in Japan, the Americas, Europe, Asia, and Oceania. It has subsidiaries in 13 locations outside Japan, and its overseas group companies and distributors provide support to customers in over 150 countries worldwide. 

  • METALTRONICA S.P.A.  -  Metaltronica S.p.A. is a market leader in diagnostic imaging and has a substantial market share in both national & international markets. The firm has experience in designing & manufacturing mammography systems for more than 40 years. It has collaborations with several universities, hospitals, and research institutes, which helps the company constantly improve its equipment. 

  • IMS S.R.L  -  IMS. S.r.l is a company that specializes in conventional radiography units and X-ray products. In 1990, the company’s production and research efforts were primarily centered on mammography and biopsy. At present, the company’s main focus is on research and development, production, and quality control, intending to offer patients and radiologists innovative and unique breast imaging technologies. The company’s products are distributed worldwide through business partners located in over 50 countries. IMS GIOTTO S.P.A., a part of the company, belongs to the GENERAL MEDICAL MERATE S.P.A. group, which is a renowned entity in the diagnostic radiology sector. 

  • GE HEALTHCARE  -  GE Healthcare, a branch of the General Electric Company, is a prominent player in the global medical technology, diagnostics, and digital solutions industry. The firm provides a wide range of products and services, including drug discovery, medical diagnostics, patient monitoring systems, medical imaging, biopharmaceutical manufacturing technologies, and performance solution services. These offerings are marketed worldwide to hospitals, medical facilities, biotechnology firms, pharmaceutical companies, and the life sciences sector. Each year, the company allocates over USD 1 billion for research and development. With 4 million imaging, diagnostic, and monitoring units worldwide, GE Healthcare has a presence in over 170 countries. 

  • PLANMED OY  -  Planmed Oy, a Finnish company, specializes in the creation, production, and promotion of sophisticated imaging equipment and accessories. Their product line, renowned for its imaging capabilities, user-friendly design, and ergonomic features, includes tools for mammography and orthopedic imaging. Planmed Oy’s products are utilized by healthcare professionals in more than 80 countries around the globe, with a significant market presence in Europe, Japan, Oceania, and the Americas. The company is a member of the Planmeca Group, a recognized entity in the medical and dental sectors. 

  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD  -  Mindray Bio-Medical Electronics Co., Ltd., a global company, is deeply involved in the production, development, and distribution of medical devices. The company’s operations are divided into three segments: in vitro diagnostics products, medical imaging systems, and patient monitoring & life support products. The in vitro diagnostics product segment provides a variety of services, including hematology analysis, immunoassay analysis, biochemistry analysis, coagulation analysis, flow cytometry, and various reagents used in IVD procedures. The patient monitoring & life support products segment provides devices for monitoring blood pressure, heart rate, temperature, and respiration. The medical imaging systems segment offers ultrasound devices and MRI systems. In addition, the company develops endoscope devices, orthopedic products, and healthcare IT solutions. With more than nine R&D centers, the company invests approximately 10% of its total revenue in R&D and holds over 6,400 patents. The company has an extensive distribution network in North America, Asia Pacific, and European countries. Its 39 subsidiaries serve more than 190 countries worldwide.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Mammography Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Mammography Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon